AGFA Gevaert NV

AGFA Gevaert's capital structure shows a debt-to-equity ratio of 0.67, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.78, suggesting it can cover its short-term obligations. However, the company's free cash flow is negative at -56 million EUR, and capital expenditures are -34 million EUR, indicating ongoing investment in operations. Profitability metrics are concerning, with a return on equity of -27.56% and a return on assets of -5.49%, both significantly below industry norms. The company reported a net loss of 70 million EUR and an operating loss of 34 million EUR, highlighting challenges in maintaining profitability. The company's revenue is distributed across three business groups: Agfa Graphics, Agfa HealthCare, and Agfa Specialty Products. While the healthcare segment is a core part of its operations, the company's global presence includes manufacturing in multiple countries, which may expose it to varying regional economic conditions. Looking ahead, the company's growth trajectory is uncertain. The current fiscal year outlook does not provide specific numeric deltas, but the negative operating and net income suggest a need for strategic adjustments. The company's revenue history shows a total of 1.09 billion EUR, but the absence of positive operating cash flow indicates potential challenges in sustaining growth. Risk factors include a medium liquidity risk and a key flag of negative net cash after subtracting total debt. The dilution risk is assessed as low, but the company's financial performance may necessitate future capital raising, which could affect shareholder value. Recent events include analyst estimates with a mean price target of 0.70 EUR and a median price target of 0.70 EUR. The mean recommendation is 4.00, indicating a neutral stance, with no strong buy or buy recommendations.